PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 114.60K | 131.50K | 123.70K | 197.50K | 136.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.20K | 144.10K | 233.60K | 374.80K | 244.60K |
| Operating Income | -127.20K | -144.10K | -233.60K | -374.80K | -244.60K |
| Income Before Tax | -1.70K | -178.00K | -320.20K | -290.70K | -258.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.70K | -178.00K | -320.20K | -290.70K | -258.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.70K | -178.00K | -320.20K | -290.70K | -258.20K |
| EBIT | -127.20K | -144.10K | -233.60K | -374.80K | -244.60K |
| EBITDA | -- | -- | -- | -374.70K | -244.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 91.02M | 91.02M | 90.92M | 88.52M | 88.52M |
| Average Diluted Shares Outstanding | 91.02M | 91.02M | 90.92M | 88.52M | 88.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |